Tradestie Institutional Equity Comparison Engine

IMDX vs CSTL โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CSTL Overall Edge

CSTL Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Castle Biosciences, Inc. Common Stock (CSTL) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, IMDX trades at N/M Forward P/E with -1883.2% operating margin (+115.0% YoY revenue) versus CSTL at N/M Forward P/E and -7.4% operating margin (+23.9% YoY). In options structure, IMDX sits in BREAKDOWN (12th %ile IV; Dealer Gamma Walls on Pro) against CSTL sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
IMDX N/M vs CSTL N/M Fwd P/E
Growth & Margin Winner CSTL
Op Margin -1883.2% vs -7.4% ยท YoY +115.0% vs +23.9%
Momentum & Technical Winner CSTL
1Y -73.8% vs -0.4% ยท 52W Pos 3% vs 59%
Options & Structure Winner CSTL
BREAKDOWN (12th %ile IV) vs UNCLASSIFIED (<1st %ile IV)
IMDX NASDAQ
Insight Molecular Diagnostics Inc. Common Stock
In Vitro & In Vivo Diagnostic Substances
$1.66
+4.4% 1D
Market Cap $52.1M
1M Return -45.03%
1Y Return -73.78%
Forward P/E N/M
Unified AI Score
45.5 / 100 HOLD
Tech 50.0 Fund 40.0 Flow 58.0 Mom 40.0
CSTL NASDAQ
Castle Biosciences, Inc. Common Stock
Services-Medical Laboratories
$33.41
+0.07% 1D
Market Cap $1.0B
1M Return -2.81%
1Y Return -0.43%
Forward P/E N/M
Unified AI Score
62.4 / 100 BUY
Tech 71.0 Fund 57.0 Flow 50.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: IMDX -73.78% CSTL -0.43% Spread: +73.35 pp (CSTL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
IMDX TTM Op. Margin: -1883.2% CSTL TTM Op. Margin: -7.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IMDX vs CSTL. Trailing 12-month operating profitability (IMDX -1883.2% vs CSTL -7.4%) and valuation multiples (IMDX N/M vs CSTL N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: IMDX (2) vs CSTL (6)
Institutional Metric IMDX CSTL Criterion Row Winner
Market Capitalization Scale $52.1M $1.0B Larger Scale CSTL
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +115.0% +23.9% Higher Growth IMDX
Operating Margin (TTM) Profitability -1883.2% -7.4% Higher Margin CSTL
Net Profit Margin Profitability 0.0% -6.1% Higher Margin IMDX
Return on Equity (ROE) Capital Efficiency -23603.1% -4.9% Higher ROE CSTL
52-Week Range Position Momentum 3% ($2โ€“$8) 59% ($18โ€“$44) Stronger Trend CSTL
Beta / 30D Volatility Risk Regime 2.91ฮฒ ยท 76% Vol 1.12ฮฒ ยท 53% Vol Lower Realized Risk CSTL
Unified Institutional Score Composite Signal 45.5 / 100 (HOLD) 62.4 / 100 (BUY) Higher Composite CSTL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full IMDX vs CSTL Buy Guide
IMDX BREAKDOWN
117d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 12th %ile
IV Regime Compressed (<25th %ile)
Live IMDX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CSTL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live CSTL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither IMDX nor CSTL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.